GILD

125.20

1.46% 1.80

시장 영업 전: 127.28 2.08 +1.66%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$123.40

열려 있는:

$123.75

하루 거래량:

9.24M

Relative Volume:

1.35

시가총액:

$155.35B

수익:

$29.05B

순이익/손실:

$8.11B

주가수익비율:

19.39

EPS:

6.4563

순현금흐름:

$9.16B

1주 성능:

+1.46%

1개월 성능:

+5.91%

6개월 성능:

+23.43%

1년 성능:

+35.16%

1일 변동 폭

$123.60

$127.68

1주일 범위

$117.13

$127.68

52주 변동 폭

$86.08

$127.68

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1103)

산업

Drug Manufacturers - General (20)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,600

트위터

@GileadSciences

다음 수익 날짜

2025-02-11

최신 SEC 제출 서류

GILD's Discussions on Twitter

GILD을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	125.20	153.10B	29.05B	8.11B	9.16B	6.4563
LLY Lilly Eli Co	1,022.87	910.93B	59.42B	18.41B	6.44B	20.22
JNJ Johnson Johnson	195.25	468.34B	92.15B	25.12B	20.46B	10.36
ABBV Abbvie Inc	232.29	412.21B	59.64B	2.36B	19.68B	1.3253
NVS Novartis Ag Adr	131.91	253.84B	54.45B	14.42B	17.15B	7.333
MRK Merck Co Inc	92.93	226.98B	63.90B	19.05B	13.05B	7.5596

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

05:48 AM

Credit Capital Investments LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat

05:48 AM

04:56 AM

Gilead Sciences, Inc. $GILD Shares Sold by Candriam S.C.A. - MarketBeat

04:56 AM

Nov 13, 2025

Gilead Sciences EVP Telman sells $6.59 million in stock By Investing.com - Investing.com Nigeria

Nov 13, 2025

Gilead Sciences EVP Telman sells $6.59 million in stock - Investing.com India

Nov 13, 2025

Can Gilead Sciences Inc. stock continue upward trendJuly 2025 Action & Pattern Based Trade Signal System - newser.com

Nov 13, 2025

Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV-1 treatment meets primary endpoint in Phase 3 ARTISTRY-1 trial - European AIDS Treatment Group

Nov 13, 2025

Gilead Sciences (NASDAQ:GILD) Hits New 1-Year HighHere's What Happened - MarketBeat

Nov 13, 2025

Will Gilead Sciences Inc. (GIS) stock outperform energy sector in 2025Market Activity Report & Risk Controlled Daily Trade Plans - newser.com

Nov 13, 2025

Gilead says single-tablet option matches complex HIV regimens in Phase III study - FirstWord Pharma

Nov 13, 2025

GILD's Price Target Raised by Needham to $140.00 | GILD Stock Ne - GuruFocus

Nov 13, 2025

Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV - Stocktwits

Nov 13, 2025

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial - Benzinga

Nov 13, 2025

Gilead stock rises after positive HIV treatment trial results By Investing.com - Investing.com Canada

Nov 13, 2025

Gilead stock rises after positive HIV treatment trial results - Investing.com

Nov 13, 2025

Gilead Sciences (GILD) Achieves Key Milestone in HIV Treatment T - GuruFocus

Nov 13, 2025

Gilead Sciences’ Strategic Advancements in HIV Treatment Bolster Buy Rating and Future Revenue Prospects - TipRanks

Nov 13, 2025

Needham Adjusts Gilead Sciences Price Target to $140 From $133, Maintains Buy Rating - MarketScreener

Nov 13, 2025

Gilead hits late-stage trial win for new single-tablet HIV therapy - Seeking Alpha

Nov 13, 2025

What drives Gilead Sciences Inc GIS stock priceGap Fill Strategies & Stay Safe With Built-In Risk Monitoring - earlytimes.in

Nov 13, 2025

What drives Gilead Sciences Inc. stock priceGlobal Market Influence & Free Tap Rapid Wealth - earlytimes.in

Nov 13, 2025

Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings - Fierce Pharma

Nov 13, 2025

Gilead (GILD) Reveals Promising Phase 3 Trial Results for HIV Tr - GuruFocus

Nov 13, 2025

Gilead Reports Positive Phase 3 Results For Bictegravir/ Lenacapavir Single-tablet Regimen For HIV - Nasdaq

Nov 13, 2025

Gilead reports positive results for HIV single-tablet regimen By Investing.com - Investing.com Australia

Nov 13, 2025

Daiwa Securities Adjusts Gilead Sciences Price Target to $129 From $128, Maintains Outperform Rating - MarketScreener

Nov 13, 2025

This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Nov 13, 2025

Can Gilead Stock Outrun Regeneron In The Next Rally? - Forbes

Nov 13, 2025

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV-1 Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-1 Trial - Yahoo Finance

Nov 13, 2025

Geode Capital Management LLC Buys 727,515 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Nov 13, 2025

United Asset Strategies Inc. Sells 2,099 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Nov 13, 2025

Gilead Sciences, Inc. $GILD Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat

Nov 13, 2025

KBC Group NV Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Nov 13, 2025

Gilead price attacks pivotal resistanceForecast today13-11-2025 - Economies.com

Nov 13, 2025

National Pension Service Sells 211,960 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Nov 13, 2025

Midwest Trust Co Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Nov 13, 2025

Scotiabank Initiates Gilead Sciences at Sector Outperform With $140 Price Target - MarketScreener

Nov 13, 2025

Will Gilead Sciences Inc. (Common Stock) (GIS0) stock outperform Dow JonesOil Prices & Target Return Focused Stock Picks - newser.com

Nov 13, 2025

Nov 12, 2025

What makes Gilead Sciences Inc. (Common Stock) (GIS0) stock appealing to growth investors2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com

Nov 12, 2025

Assessing Gilead After 34% Rally and Recent Pharmaceutical Partnerships - Yahoo Finance

Nov 12, 2025

UPDATED: J&J, Legend withdraw ASH abstract assessing Carvykti against Gilead, Arcellx's rival CAR-T - Fierce Pharma

Nov 12, 2025

Gilead Sciences stock reaches all-time high at 124.63 USD By Investing.com - Investing.com Australia

Nov 12, 2025

Gilead Sciences stock reaches all-time high at 124.63 USD - Investing.com

Nov 12, 2025

‘Why We Would Do It Again’ – Gilead & Roche On Pioneering Global Initiative For Manufacturing Change - Citeline News & Insights

Nov 12, 2025

VeraBank N.A. Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Nov 12, 2025

Simplify Asset Management Inc. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Nov 12, 2025

Gilead Sciences (GILD): Assessing Valuation After Trodelvy Breast Cancer and Livdelzi PBC Data Updates - simplywall.st

Nov 12, 2025

Gilead Sciences, Inc. $GILD Stake Lessened by Forsta AP Fonden - MarketBeat

Nov 12, 2025

AGF Management Ltd. Makes New $1.40 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Nov 12, 2025

Gilead Sciences, Inc. : The underlying trend is in force again - MarketScreener

Nov 12, 2025

Using data tools to time your Gilead Sciences Inc. exitInflation Watch & Daily Oversold Bounce Ideas - newser.com

Nov 12, 2025

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know - The Globe and Mail

Nov 12, 2025